CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeti

[
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeti
[og_img]
https://www.investing.com/news/press-releases/cg-oncology-announces-bestindisease-durability-data-in-bond003-cohort-c-and-promising-early-signal-in-cohort-p-for-cretostimogene-grenadenorepvec-at-the-american-urological-association-annual-meeti-93CH-4005890


Investing.com